%PDF-1.7 % 16 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20221119030308-05'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 17 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 6 0 R 7 0 R 8 0 R 9 0 R 10 0 R 11 0 R ] /PZ 1 >> endobj 17 0 obj <> stream x[]s6}㗴3C?xٌ6ig>@$$bM*J^|Hl%igJȒI乸8 ~Ǐ ?{qj /MDAh_0ÿg} Hv;_R4iOs;\\j.P7l0?P 8_^q/7|WicA;anXD)NSau3= h=qM< Eq*DEs;W ^k3O7N>/fp1wW2GQdRBn/gC\)|0 4F fy:~tyX=Hn/1O( Do<;5kIIs&뽋$` ^OpjIr(ˋsPLTp%T: MʏW~?~z"sĻˊzJֲN5gyD&R6rj\_>')$s&x9(z[F 3q njJ(?z endstream endobj 18 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20221119030308-05'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 19 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 12 0 R 13 0 R 15 0 R ] /PZ 1 >> endobj 19 0 obj <> stream xVKs0W1e!ܦLЙ$ M "}IjbO+m]Kp ( /J<\o'Ɲ/-,B]%do,&\.\NWgi'@#ApnQl!l ] >~ߞ4a'y=ѫ oWW|!\xp!JLh]­`0 D$Kp F'# W2 d8 @9)QK\@xr!M_Yq0doY1əVd:e FZp̱YaaZPnabL^\z)z#weQHLVEszݼ"^MtF?"l^Eؼ5Sh;6r-K(BuiKeL2gĤ%O벂pm}YDzc׶{rM7j:}:WIR@28/ᓌL]"u2<Ԧ0(L42ĀHi0 ysS ,4 Ss}LhrZP]5 4P=Vqa}3Qi T:1FE]IQ`G z2͒jIi: PtN W/e'j7W2"5@UR9_Wء"&QzO{>)q|.v]}@x!8c-HsF\.lk}yھ>s'=q"Jlcr(]"˓ endstream endobj 1 0 obj << /Type /Pages /Kids [ 16 0 R 18 0 R ] /Count 2 >> endobj 3 0 obj <> endobj 5 0 obj <> endobj 14 0 obj <> endobj 20 0 obj <> stream JFIFHHExifMM* z(1>?QQ Q HHPaint.NET v3.5.10z%u0`:oCC." }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?(f 1T$`9Sw(B@;~(]Cd꾫Es:aݻd2\(2F][&]ۢϲ|W͵L@A A 8 (CĝCglZE/ |Ezє{ xQʒ@[ྊ\/I4R0?6.7`ŴwPu|3/Z@Ogi}cFdFKoj?~8|p_A<ĺOkGPK $wRmkmF;YVx&rLj#p ׭axf|s$Ӿc:Qwm]N)Cψ[eYba98xB+oTÚwcRþ$U[ ?qΙ{&jv6Xo$=ԗ&7zgAxIִ.$3,mwc{+%g[!U@&Fϻm/#hci'7n[%It.&/ֶ+Zl~:wi~D>$}o+}@.[/+B6mnt8bi{zc.~F{eUe86g3 VT&> BK VؘXzSMesoM_&ϔIÍK?+hڿnt_ K]H '̽yrWA=O+|"!gɤItXe>Xs hwwG Eouqa /ş_~~'x} ]_^]/ 蚼:<cu/ h&omEۯicǪ\[,k}_uS}㏆W]G^tmf`Ks ]=va&h9n忔>75NWQτ0of,E (˰8hBC_ Jq'W UQKz,N>+`S%}b5ISJ]+(&QVN>eoy7xG4[]]3K{i$I>g-(mbynLIC,"*3f?-%`lfPx涽X"H'h"ֈ(TfeU:܉,a,R*I4xcxalOhGр|ia$cg,{gAHEu->]F,{-.,EX"I$XQD/3R.{{T&ҭ%4[OPnx"HhM :e}-Լ'=s:\iZ<+Lj5+1AɮLZx-☽G3 1I"kuχ+A}5'NxI8 gJk[oenm!x,=n=>}kjPx~M񧍼5k45a,RLiȖTFQMR&K;}r+XkY[y>2F=2~6>Gmi++<[WF76MH4>;;Kf۽ъM3ZE}c㿈*- -.|G5uI![ YR$$A>Eyׇ|7u;n>4׭JϷR[h!rVr\{~Ϛ >0jMg?_y_ Do/x;ÚƏi a𶕦f|Eqgk4V^RY]}F,/J%ՌAud%:x3Hg_4[+^ ҴKaXF'n.]Z(i$bef5GO:u]/a~.3N4xiG*a8ާ-U){G nJEڿ[m7wv5MYp|'gm # #%B?|鿲w­{+_|Q#VkxcZޛ{I]Wyak}..i˨iY9QwOA~hf{+ |Y;cڴ27G>|H,na8o; CEO,ZLP?SHK} e92W7/1aj¤aڄq4 қS7,5]%EƔc/uҒw\r/EnT y>!V+VK4X^Y{;+Ӫ=MqslEn?Zz'Ë}^2xĺGf70/M~*DU=坍G{wwvci%vZ$GY&J9dkՀ\6hs.F*ĩ"+S%s*{ qqDj3$ q^T24,Cn +=j񟍼q5k'\%ݎ{ͦuyq4X$y<ك2Ey%™|Icw]3#R[`{KցY [1*kLOdw ^OAkЏb<¿ <=6x0ׄ>(=*[ t]9-?IZ@}/>FۃQ@ endstream endobj 4 0 obj << /Type /XObject /Subtype /Form /FormType 1 /Filter /FlateDecode /BBox [0.000000 0.000000 595.276000 76.535433] /Matrix [1 0 0 1 0 0] /Resources << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F2 5 0 R /F1 3 0 R >> /XObject << /I0 20 0 R >> >> /Length 197 >> stream xKkBA WeI&ڊU/ nʥBf8A3!(X4`JQj*Aj͕197f hkL[=µrw]F D%x2WC0 9)Z ^Wh}29yyu?4g=bT1߻a endstream endobj 2 0 obj << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F1 3 0 R /F2 5 0 R /F3 14 0 R >> /XObject << /XT4 4 0 R /I0 20 0 R >> >> endobj 6 0 obj <> /H /I>> endobj 7 0 obj <> /H /I>> endobj 8 0 obj <> /H /I>> endobj 9 0 obj <> /H /I>> endobj 10 0 obj <> /H /I>> endobj 11 0 obj <> /H /I>> endobj 12 0 obj <> /H /I>> endobj 13 0 obj <> /H /I>> endobj 15 0 obj <> /H /I>> endobj 21 0 obj << /Title (New Phase 1 clinical trial to test Durvalumab in pediatric patients) /Subject (New Phase 1 clinical trial to test Durvalumab in pediatric patients) /Creator (Science X Network) /Producer (TCPDF 6.3.5 \(http://www.tcpdf.org\)) /CreationDate (D:20221119030308-05'00') /ModDate (D:20221119030308-05'00') /Trapped /False >> endobj 22 0 obj << /Type /Metadata /Subtype /XML /Length 4791 >> stream application/pdf New Phase 1 clinical trial to test Durvalumab in pediatric patients New Phase 1 clinical trial to test Durvalumab in pediatric patients 2022-11-19T03:03:08-05:00 Science X Network 2022-11-19T03:03:08-05:00 2022-11-19T03:03:08-05:00 TCPDF 6.3.5 (http://www.tcpdf.org) uuid:f167c3b5-ddc2-3e09-7fc0-229b0e209403 uuid:f167c3b5-ddc2-3e09-7fc0-229b0e209403 http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema internal Adobe PDF Schema InstanceID URI http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text endstream endobj 23 0 obj << /Type /Catalog /Version /1.7 /Pages 1 0 R /Names << >> /ViewerPreferences << /Direction /L2R >> /PageLayout /SinglePage /PageMode /UseNone /OpenAction [16 0 R /FitH null] /Metadata 22 0 R >> endobj xref 0 24 0000000000 65535 f 0000003834 00000 n 0000010370 00000 n 0000003901 00000 n 0000009869 00000 n 0000004007 00000 n 0000010517 00000 n 0000010764 00000 n 0000011011 00000 n 0000011262 00000 n 0000011511 00000 n 0000011761 00000 n 0000012013 00000 n 0000012303 00000 n 0000004118 00000 n 0000012592 00000 n 0000000015 00000 n 0000000517 00000 n 0000002504 00000 n 0000002989 00000 n 0000004233 00000 n 0000012810 00000 n 0000013350 00000 n 0000018224 00000 n trailer << /Size 24 /Root 23 0 R /Info 21 0 R /ID [ ] >> startxref 18434 %%EOF